Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma

Clinical trial NCT00734864 · WITHDRAWN

Trial details

NCT number: NCT00734864
Sponsor: Annick Desjardins
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Glioblastoma Multiforme Gliosarcoma Anaplastic Astrocytoma Anaplastic Oligodendroglioma Glioma

Start date: 2009-06-01
Primary completion: 2010-06-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.